Meridian Investment Counsel’s Medovex Corp. Common Stock MDVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-100,000
Closed -$112K 196
2017
Q3
$112K Buy
100,000
+50,000
+100% +$51.8K 0.06% 180
2017
Q2
$42K Hold
50,000
0.03% 179
2017
Q1
$76K Hold
50,000
0.05% 179
2016
Q4
$66K Hold
50,000
0.04% 168
2016
Q3
$74K Hold
50,000
0.05% 168
2016
Q2
$66K Hold
50,000
0.04% 166
2016
Q1
$52K Buy
+50,000
New +$62.4K 0.04% 170

Meridian Investment Counsel's MDVX Position: Q4 2017 in Review

Meridian Investment Counsel sold out of Medovex Corp. Common Stock (MDVX) in Q4 2017, closing a stake of 100,000 shares — an estimated $112K sold.

Meridian Investment Counsel first reported a position in MDVX in Q1 2016 and held it in 7 quarters. The position peaked at $112K in Q3 2017. 0 funds tracked by Wall St. Rank hold MDVX as of Q4 2017.

  • Meridian Investment Counsel reported no remaining Medovex Corp. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Meridian Investment Counsel sold 100,000 Medovex Corp. Common Stock shares in Q4 2017, an estimated $112K.
  • Meridian Investment Counsel first reported a position in Medovex Corp. Common Stock in Q1 2016 and held it in 7 quarters.
  • Meridian Investment Counsel's Medovex Corp. Common Stock position peaked at $112K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q4 2017.

Based on Meridian Investment Counsel's 13F filing for Q4 2017, filed 13 Feb 2018.